Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO-128-1-131PMID 1986914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.

  1990cited by this paper
• The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.

  1990cited by this paper
• The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat.

  1990cited by this paper
• Oxytocin, vasoactive-intestinal peptide, and serotonin regulate the mating-induced surges of prolactin secretion in the rat.

  1990cited by this paper
• Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.

  1990cited by this paper
• Central actions of adenosine on pituitary secretion of prolactin, luteinizing hormone and thyrotropin.

  1989cited by this paper
• Central actions of adenosine on pituitary secretion of prolactin, luteinizing hormone and thyrotropin.

  1989cited by this paper
• Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.

  1989cited by this paper
• Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumour cells in vitro.

  1989cited by this paper
• Effects of passive immunization against vasoactive intestinal peptide on serum prolactin and LH levels.

  1989cited by this paper
• The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.

  1989cited by this paper
• Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism.

  1989cited by this paper
• Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.

  1989cited by this paper
• Neuroendrocrine regulation of prolactin release

  1989cited by this paper
• Neuroendocrine [corrected] regulation of prolactin release.

  1989cited by this paper
• Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland.

  1989cited by this paper
• Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.

  1989cited by this paper
• Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.

  1988cited by this paper
• Autocrine control of prolactin secretion by vasoactive intestinal peptide.

  1988cited by this paper
• Changes in tuberoinfundibular dopaminergic neuron activity during the rat estrous cycle in relation to the prolactin surge: alteration by a mammary carcinogen.

  1988cited by this paper
• Neuroendocrine Significance of Vasoactive Intestinal Polypeptide a

  1988cited by this paper
• Reduced vasoactive intestinal polypeptide immunoreactivity in the pituitaries of hormone-deficient mutant mice.

  1988cited by this paper
• Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.

  1987cited by this paper
• Correlation of rat pituitary prolactin messenger ribonucleic acid and hormone content with serum levels during the estrogen-induced surge.

  1987cited by this paper
• Hormonal changes during the early development of ovarian cysts in the rat.

  1986cited by this paper
• Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue.

  1986cited by this paper
• Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.

  1986cited by this paper
• Effect of estrogen on prolactin mRNA in the rat pituitary. Analysis by in situ hybridization and immunohistochemistry.

  1986cited by this paper
• Vasoactive intestinal peptide.

  1986cited by this paper
• Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat.

  1985cited by this paper
• Equol: a contributor to enigmatic immunoassay measurements of estrogen.

  1985cited by this paper
• Vasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells.

  1985cited by this paper
• The distribution and chromatographic characterization of PHI (peptide histidine isoleucine amide)-27-like peptides in rat and porcine brain

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Characterization of estrogen-induced adenohypophyseal tumors in the Fischer 344 rat.

  1983cited by this paper
• Interaction between estradiol and prolactin on vasoactive intestinal peptide concentrations in the hypothalamus and in the anterior pituitary of the female rat.

  1982cited by this paper
• Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland.

  1982cited by this paper
• A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats.

  1981cited by this paper
• Neuroendocrine control of thyrotropin secretion.

  1981cited by this paper
• Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.

  1981cited by this paper
• A possible cause for the differing responses of the luteinizing hormone surge mechanism of ovariectomized rats to short term exposure to estradiol.

  1980cited by this paper
• The use of specific radioimmunoassays to determine the renal clearance rates of estrone and 17 beta-estradiol during the menstrual cycle.

  1978cited by this paper
• Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat.

  1974cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.

  2013cites this paper
• Forced swim test behavior in postpartum rats.

  2010cites this paper
• Increases in the size, number and proliferation rate of VIP-immunoreactive pituitary cells induced in vitro by TRH are associated with increases in VIP release

  2003cites this paper
• Local action of estrogen and thyroid hormone on vasoactive intestinal peptide (VIP) and galanin gene expression in the rat anterior pituitary.

  2002cites this paper
• Organization of vasoactive intestinal peptide-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development.

  2001cites this paper
• Persistent increase of PRL after oral contraceptive treatment

  1999cites this paper
• Distribution of vasoactive intestinal peptide-like immunoreactivity in the brain and pituitary of the frog (Rana esculenta) during development.

  1999cites this paper
• Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status.

  1997cites this paper
• Vasoactive Intestinal Polypeptide mRNA and Peptide Levels are Decreased in the Anterior Pituitary of the Human Growth Hormone‐Releasing Hormone Transgenic Mouse

  1996cites this paper
• Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats.

  1996cites this paper
• In vitro morphometric and proliferative variations in VIP-immunoreactive pituitary cells induced by estradiol.

  1995cites this paper
• Estradiol Induces Vasoactive Intestinal Peptide and Prolactin Gene Expression in the Rat Anterior Pituitary Independently of Plasma Prolactin Levels

  1995cites this paper
• Possible Changes in the Regulatory Mechanisms of Pulsatile Luteinizing Hormone Secretion in Adult Pituitary-Grafted Female Rats

  1995cites this paper
• Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.

  1994cites this paper
• In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells.

  1994cites this paper
• Median eminence-afferent vasoactive intestinal peptide (VIP) neurons in the hypothalamus: localization by simultaneous tract tracing and immunocytochemistry.

  1993cites this paper
• Ablation of the hypothalamic arcuate-median eminence region reduces the concentration of vasoactive intestinal peptide in the anterior pituitary gland of male rats.

  1993cites this paper
• and Kinesin in Rat Testis1

  1992cites this paper
• Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.

  1992cites this paper
• Distribution of the microtubule-dependent motors cytoplasmic dynein and kinesin in rat testis.

  1992cites this paper
• Regulation of pulsatile gonadotropin secretion by estrogen, inhibin, and follistatin (activin-binding protein) in ovariectomized rats.

  1992cites this paper
• Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat.

  1992cites this paper
• A comparative study of the effects of neonatal androgenization and estrogenization on vasoactive intestinal peptide levels in the anterior pituitary and the hypothalamus of adult female rats.

  1992cites this paper
• Neonatal androgenization increases vasoactive intestinal peptide levels in rat anterior pituitary: possible involvement of vasoactive intestinal peptide in the neonatal androgenization-induced hyperprolactinemia

  1991cites this paper